They are small, protein-forward, easy to tolerate, and realistic on tired days
To view or add a comment, sign in #AgiosNews: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion for the new indication for our first-in-class pyruvate kinase (PK) activator for the treatment of anemia in adult patients with #thalassemia
Awareness of genetic predispositions to ageing supports personalised recommendations that help sustain optimal health and quality of life
The exposure groups were well balanced across all covariates, with no standardised difference above 0.02
Advantages of metformin include the longstanding research supporting its efficacy and safety, an expected decrease in the glycated hemoglobin (HbA1c) level of 1% to 1.5%, low cost, minimal hypoglycemic risk, and potential reductions in cardiovascular (CV) events due to decreased low-density lipoprotein (LDL) cholesterol
Read clinical review Dosing & Monitoring GIP/GLP-1 Dual Agonists Titration & Tapering Algorithms A clinician-level guide to tirzepatide titration schedules, dose-escalation pacing, GI tolerability management, and evidence-based tapering strategies for GIP/GLP-1 dual agonists